cgp 12177 has been researched along with Carcinoma, Hepatocellular in 1 studies
CGP 12177 : A benzimidazole that is benzimidazol-2-one substituted at position 4 by a 3-(tert-butylamino)-2-hydroxypropoxy group.
Carcinoma, Hepatocellular: A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kassahun, WT | 1 |
| Guenl, B | 1 |
| Ungemach, FR | 1 |
| Jonas, S | 1 |
| Abraham, G | 1 |
1 other study available for cgp 12177 and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
Expression and functional coupling of liver β2 - adrenoceptors in the human hepatocellular carcinoma.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adult; Aged; Carcinoma, Hepatocellular; Femal | 2012 |